Procter & Gamble Co. buy BNP Paribas Exane
Start price
27.09.25
/
50%
€130.46
Target price
27.09.26
€146.97
Performance (%)
-3.36%
Price
07.08.26
€126.08
Summary
This prediction is currently active. With a performance of -3.36%, the BUY prediction for Procter & Gamble Co. by BNP_Paribas_Exane is down slightly. This prediction currently runs until 27.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Procter & Gamble Co. | 0.606% | 0.606% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Procter & Gamble Co. diskutieren
Procter & Gamble (NYSE:PG) had its price target lowered by analysts at BNP Paribas Exane from $177.00 to $172.00. They now have an "outperform" rating on the stock.
Ratings data for PG provided by MarketBeat
Stopped prediction by BNP_Paribas_Exane for Procter & Gamble Co.
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€123.44
23.04.26
23.04.26
€141.04
23.04.27
23.04.27
2.14%
07.08.26
07.08.26
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€124.98
18.01.26
18.01.26
€141.30
18.01.27
18.01.27
0.88%
07.08.26
07.08.26